Crf1 thiazole pyrazolopyrimidine as receptor antagonists

The present invention provides compounds of formula I, pharmaceutical compositions thereof, as well as psychiatric and neuroendocrine disorders, their use as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of neurological diseases and metabolic syndrome .